Market Insights
The inferior vena cava (IVC) is the largest vein in the human body that carries deoxygenated blood from the inferior part of the body to the heart. An inferior vena cava filter is implanted in the inferior vena cava to capture emboli and blood clots, preventing them from reaching the lungs. Implantation of these devices is either permanent or temporary, depending on the need for therapy. The prominent factors that fuel the growth of the global inferior vena cava (IVC) filters market include the rise in preference for minimally invasive surgeries with improved medical imaging across various medical settings. However, the global market’s growth is restricted by the high cost of procedures associated with IVC filters. Furthermore, the emergence of digital catheterization laboratories is anticipated to offer lucrative opportunities for the expansion of the market. According to the American Thoracic Society, in 2016, the incidence of diagnosed pulmonary embolism ranged from 71 to 117 per 100,000 people per year in the United States. High diagnosis rates of pulmonary embolisms contribute to the growth of the global market.
The global IVC filter market is segmented based on product types, end-users, and geography. Based on product type, the global IVC filter market is classified as having either permanent inferior vena cava filters or retrievable inferior vena cava filters. Based on end-user, the market is segmented into hospitals, ambulatory surgical centers (ASCs), and others. Among end-user segments, hospitals dominated the global market in 2017 and are anticipated to retain their prominence during the forecast period due to the high usage of IVC filters for cardiac surgeries.
Geographically, North America dominated the global market owing to the high prevalence and awareness of cardiovascular diseases and the availability of an evolved healthcare infrastructure. Manufacturers are focusing on emerging markets, including Asia Pacific and Latin America, for further expansion due to the presence of potential opportunities.
The Global Inferior Vena Cava (IVC) Filters Market is classified as follows:
Global Inferior Vena Cava (IVC) Filters Market, by Product Type, 2016–2026 (US$ Mn)
- Retrievable IVC Filter
- Permanent IVC Filter
Global Inferior Vena Cava (IVC) Filters Market, by End-User, 2016–2026 (US$ Mn)
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Inferior Vena Cava (IVC) Filters Market, by Geography, 2016–2026 (US$ Mn)
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
The following companies have been identified as key players in the Inferior Vena Cava (IVC) Filters Market:
Cardinal Health, Inc., Boston Scientific Corporation, Cook Medical, ALN, C. R. Bard, Braile Biomedical, B. Braun Melsungen AG, VENITI, Inc., Argon Medical Devices, Inc., and Koninklijke Philips N.V.
This report offers the following:
- A comprehensive market outlook of the global inferior vena cava filters market, along with future trends
- By segmenting the market based on various parameters, the global inferior vena cava filters market elucidation at a granular level.
- Estimates of the global inferior vena cava filters market for the ten-year period 2016-2026, as well as quantification of market growth from 2018 to 2026.
- Profiling of the key players operating in the inferior vena cava filters market, along with graphical positioning of the major players
